This work was supported by a grant from the National Natural Science Foundation of China (No. 30772277).
Background P53 is one of the most studied tumor suppressors in the cancer research, and over 50% of human tumors carry P53 mutations. MDM-2 is amplified and/or overexpressed in a variety of human tumors of diverse tis...